Cargando…
Management precautions for risk of obesity are necessary among infants with PKU carrying the rs113883650 variant of the LAT1 gene: A cross-sectional study
Patients with phenylketonuria (PKU), an inborn error of phenylalanine metabolism, require consistent treatment to avoid the brain toxicity caused by hyperphenylalaninemia. The treatment consists of life-long use of a low-phenylalanine diet, which aims at decreasing hyperphenylalaninemia and maintain...
Autores principales: | Bik-Multanowski, Miroslaw, Didycz, Bozena, Bik-Multanowska, Kinga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853486/ https://www.ncbi.nlm.nih.gov/pubmed/35176108 http://dx.doi.org/10.1371/journal.pone.0264084 |
Ejemplares similares
-
The rs113883650 variant of SLC7A5 (LAT1) gene may alter brain phenylalanine content in PKU
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2021) -
Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria
por: Bik-Multanowski, Miroslaw, et al.
Publicado: (2020) -
Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria
por: Didycz, Bozena, et al.
Publicado: (2017) -
Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
por: van Vliet, Danique, et al.
Publicado: (2019) -
Long-term Trends in the Prevalence of Congenital Heart Defects in Patients with Down Syndrome in Southern Poland
por: Dobosz, Artur, et al.
Publicado: (2019)